AbbVie e Genmab recebem designação de terapia inovadora para tratamento de linfoma folicular recidivante ou refratário

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AbbVie e Genmab recebem designação de terapia inovadora para tratamento de linfoma folicular recidivante ou refratário

/jornal/2023/11/abbvie-e-genmab-recebem-designacao-de-terapia-inovadora-para-tratamento-de-linfoma-folicular-recidivante-ou-refratario/

Abbvie (BOV:ABBV34)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Abbvie Charts.

Abbvie (BOV:ABBV34)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Abbvie Charts.

News

Real-Time news about Abbvie Inc (Brazil Bovespa Exchange): 0 recent articles

More News Articles

ProText Mobility (PK)

Ubiquitech Software (PK)

Iovance Biotherapeutics

Brookmount Explorations (PK)

Bioelectronics (PK)

Atlantic Energy Solutions (PK)

Cann American (CE)

NioCorp Developments

Clean Vision (QB)

Greene Concepts (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions